Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels
Hatfield, K J, Hovland, R, Øyan, A M, Kalland, K H, Ryningen, A, Gjertsen, B T, Bruserud, Ø
Published in Leukemia (01.02.2008)
Published in Leukemia (01.02.2008)
Get full text
Journal Article
Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients
Reikvam, H., Øyan, A. M., Kalland, K. H., Hovland, R., Hatfield, K. J., Bruserud, Ø.
Published in Cell proliferation (01.10.2013)
Published in Cell proliferation (01.10.2013)
Get full text
Journal Article
Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies
Hatfield, Kimberley J, Olsnes, Astrid M, Gjertsen, Bjorn Tore, Bruserud, Øystein
Published in Current cancer drug targets (01.06.2005)
Published in Current cancer drug targets (01.06.2005)
Get more information
Journal Article